Federal Register / Vol. 60, No. 50 / Wednesday, March 15, 1995 / Notices 13999

PUBLIC SCOPING MEETING: To ensure that

all issues relating to the proposed

project are identified and all potentially

significant issues are addressed and

satisfied in the EIS, public comments

and suggestions are being solicited. To

facilitate the receipt of comments, a

public scoping meeting will be held on

Monday, March 20, 1995 from 2 p.m. to

4 p.m. and from 6 p.m. to 8 p.m. in the

auditorium of the Joseph Addabbo

Federal Building, 1 Jamaica Center

Plaza, Jamaica, New York.

Written comments may be mailed to

the informational contact person no

later than April 7, 1995.

Issued in New York City, New York on

March 7, 1995.

Karen R. Adler,

Regional Administrator, General Services

Administration, Region 2.

[FR Doc. 95–6289 Filed 3–14–95; 8:45 am]

BILLING CODE 6820–23–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

Board of Scientific Counselors,

Agency for Toxic Substances and

Disease Registry: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Agency for Toxic

Substances and Disease Registry

(ATSDR) announces the following

committee meeting.

Name: Board of Scientific Counselors,

ATSDR.

Times and dates: 8:30 a.m.–5:00 p.m.,

April 20, 1995. 8:30 a.m.–12:40 p.m., April

21, 1995.

Place: The Centers for Disease Control and

Prevention, Auditorium A, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: The entire meeting will be open to

the public.

Purpose: The Board of Scientific

Counselors, ATSDR, advises the

Administrator, ATSDR, on ATSDR programs

to ensure scientific quality, timeliness,

utility, and dissemination of results.

Specifically, the Board advises on the

adequacy of the science in ATSDR-supported

research, emerging problems that require

scientific investigation, accuracy and

currency of the science in ATSDR reports,

and program areas to emphasize and/or to deemphasize.

Agenda: The Agenda will include an

update on Superfund reauthorization and

will also focus on other issues of concern to

ATSDR, including ATSDR’s programs for

physician and community education,

development of the medical assistance

program, progress report by the Board of

Scientific Counselors, ATSDR, work group

on health studies, and an overview of the

ATSDR Great Lakes Human Health Effects

Research Program.

Written comments are welcome and should

be received by the contract person listed

below prior to the opening of the meeting.

Contact person for more information:

Charles Xintaras, Sc.D., Executive Secretary,

Board of Scientific Counselors, ATSDR,

Mailstop E–28, 1600 Clifton Road, NE.,

Atlanta, Georgia 30333, telephone 404/639–

0708.

Dated: March 8, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–6318 Filed 3–14–95; 8:45 am]

BILLING CODE 4163–70–M

National Institutes of Health Genome

Research Review Committee; Notice

of Cancellation of Meeting

Notice is hereby given of the

cancellation of the meeting of the

Genome Research Review Committee,

National Center for Human Genome

Research, March 14, 1995, Embassy

Suites Hotel, Chevy Chase Pavilion,

Washington, D.C. which was published

in the Federal Register on March 3, 1995

(60 FR 11975).

The meeting was cancelled due to

complications of other commitments of

several members of the committee and

will be rescheduled at a later date.

Dated: March 9, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6326 Filed 3–14–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of a Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Review of the Vascular

Disease Academic Award.

Date: April 9–10, 1995.

Time: 7 p.m.

Place: Holiday Inn, Chevy Chase,

Maryland.

Contact Person: S. Charles Selden, Ph.D.,

5333 Westbard Avenue, Room 552, Bethesda,

Maryland 20892, (301) 594–7476.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in

accordance with the provisions set forth

in sec. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: March 9, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6398 Filed 3–14–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of a Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Mechanisms of Post Bone

Marrow Transplantation Lung Injury.

Date: April 5–6, 1995.

Time: 7:30 p.m.

Place: Holiday Inn, Chevy Chase,

Maryland.

Contact Person: Dr. Lynn M. Amende, 5333

Westbard Avenue, Room 5A10, Bethesda,

Maryland 20892, (301) 594–7480.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in

accordance with the provisions set forth

in sec. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: March 9, 1995.

Margery G. Grubb,

Senior Committee Management Specialist,

NIH.

[FR Doc. 95–6397 Filed 3–14–95; 8:45 am]

BILLING CODE 4140–01–M